David A. Tuveson, MD, PhD, FAACR
President-Elect

David A. Tuveson, MD, PhD, FAACR

Director and Roy J. Zuckerberg Professor of Cancer Research
Cold Spring Harbor Laboratory (CSHL) Cancer Center
Cold Spring Harbor, New York

Dr. Tuveson is the director of the Cold Spring Harbor Laboratory Cancer Center in Cold Spring Harbor, New York, where he is also the Roy J. Zuckerberg professor of cancer research. Additionally, he is the chief scientist for the Lustgarten Foundation in Woodbury, New York, the largest pancreatic cancer research philanthropy. Dr. Tuveson is a medical staff affiliate at Memorial Sloan Kettering Cancer Center in New York, and also works closely with the Cancer Institute at Northwell Health on Long Island. Dr. Tuveson serves on the Board of Scientific Advisors of the National Cancer Institute. He is a world-renowned physician-scientist whose basic and translational research focuses on increasing our understanding of the biology of pancreatic cancer and on identifying and testing in preclinical and clinical settings new approaches for diagnosing and treating the disease.

An AACR member since 2003, Dr. Tuveson is a scientific editor of the AACR journal Cancer Discovery. Among his other contributions to the AACR, he previously served as vice chair for the AACR Annual Meeting Program Committee (2018-2019); chair of the Pezcoller Foundation-AACR International Award for Cancer Research Committee (2019); chair of the Plenary Session for the Special Conference, “Pancreatic Cancer: Advances in Science and Clinical Care” (2016); cochair of the Special Conference, “Pancreatic Cancer: Innovations in Research and Treatment” (2014); cochair of the Program Committee for the AACR International Conference on Frontiers in Cancer Prevention Research (2008); and cochair of the Mentored Grants and Research Fellowships Committee (2008). He has also served as a member on multiple AACR committees, including the Pancreatic Cancer Action Network-AACR Innovative Grants Scientific Review Committee (2008-2010); the Program Committee (2008) and Scientific Review Committee (2007) for the AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development; and the Annual Meeting Education Committee (2006 and 2011). In addition, Dr. Tuveson has been a member of the Scientific Advisory Committee for Stand Up To Cancer since 2012.

Dr. Tuveson was elected to the 2020 class of Fellows of the AACR Academy. He has been recognized with a host of other honors and awards throughout his career, including the Hamdan Award for Medical Research, Excellence – Pancreatic Diseases (2016), the Jan Waldenstrom Medal from the Swedish Society of Oncology (2014), the Ruth C. Brusky Award for Excellence in Clinical Research on Pancreatic Cancer, PancreasFest (2010), the Norbert and Suzanne Schnog Lectureship for Yale University (2005), the Frank Brooks Memorial Lectureship for the American Pancreatic Association (2004), the Rita Allen Foundation Scholar Award (2003), the AACR-PanCAN Career Development Award in pancreatic cancer research (2003), and the Forbeck Scholar Award from the William Guy Forbeck Research Foundation (2000). He is also an elected member of the American Society for Clinical Investigation (2016) and was a recipient of the Physician-Scientist Early Career Award from the Howard Hughes Medical Institute (1999).

Dr. Tuveson received his bachelor’s degree in chemistry from the Massachusetts Institute of Technology in 1987 and his doctoral and medical degrees from the Johns Hopkins School of Medicine in 1994. He completed his residency in internal medicine at the Brigham and Women’s Hospital in 1997, and completed a fellowship in hematology and oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center in 2000. He was a postdoctoral fellow at MIT from 1997 to 2002.